The previous report revealed that MYF5 + MuSCs have regenerative capacity for damaged muscle in Duchenne muscular dystrophy (DMD) model mice10; therefore, they are believed to be promising cell sources for regenerative therapy for muscular dystrophy. This evidence concerns the gene MYF5 and Duchenne muscular dystrophy.